Plain-English translation of NCT06917339 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Depression research guide →This study looks at real-world information from people who have already received NeuroStar treatment — a type of magnetic stimulation applied to the brain to treat depression, anxiety, and obsessive-compulsive disorder. Researchers want to learn which patients get the best results and how different treatment settings affect outcomes.
While this treatment has shown promise in clinical studies, doctors need to understand how it actually performs in everyday practice and which patients are most likely to benefit. This information will help improve how the treatment is used in the future.
You likely qualify if…
You likely don't qualify if…
In this study, you do not receive any new treatment or visit a clinic. Instead, researchers will access your existing medical records from your NeuroStar treatment to review your outcome and treatment details. This is a review of past care, so participation simply means allowing your records to be included in the analysis.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
United States
Enrollment target
~156,000 participants
Started
February 2025
Primary completion
December 2035
Age range
5 Years – 120 Years
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Neha Goyal
Neuronetics
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.